APA (7th ed.) Citation

Ebbers, S. C., Barentsz, M. W., de Vries-Huizing, D. M. V., Versleijen, M. W. J., Klompenhouwer, E. G., Tesselaar, M. E. T., . . . Lam, M. G. E. H. (2024). Intra-arterial peptide-receptor radionuclide therapy for neuro-endocrine tumour liver metastases: An in-patient randomised controlled trial (LUTIA). European Journal of Nuclear Medicine & Molecular Imaging, 51(4), 1121. https://doi.org/10.1007/s00259-023-06467-y

Chicago Style (17th ed.) Citation

Ebbers, S. C., et al. "Intra-arterial Peptide-receptor Radionuclide Therapy for Neuro-endocrine Tumour Liver Metastases: An In-patient Randomised Controlled Trial (LUTIA)." European Journal of Nuclear Medicine & Molecular Imaging 51, no. 4 (2024): 1121. https://doi.org/10.1007/s00259-023-06467-y.

MLA (9th ed.) Citation

Ebbers, S. C., et al. "Intra-arterial Peptide-receptor Radionuclide Therapy for Neuro-endocrine Tumour Liver Metastases: An In-patient Randomised Controlled Trial (LUTIA)." European Journal of Nuclear Medicine & Molecular Imaging, vol. 51, no. 4, 2024, p. 1121, https://doi.org/10.1007/s00259-023-06467-y.